Lanyan Fang

United States Food and Drug Administration

MathematicsMedicinePharmacology, Toxicology and PharmaceuticsImmunology and MicrobiologyEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Application of Advanced Modeling Approaches Supporting Generic Product Development Under GDUFA for Fiscal Year 2023”.

Application of Advanced Modeling Approaches Supporting Generic Product Development Under GDUFA for Fiscal Year 2023

The AAPS Journal(2024)10.1208/s12248-024-00924-8

N/A

0DataRank · unranked

1 citations

Yuqing Gong, Andrew Babiskin, Meng Hu, Youssef M. Mousa, Ross Walenga +9 more

Using Lung Regional Deposition Modeling as Model-Integrated Evidence for Locally Acting Orally Inhaled Drug Products

Pharmaceutical Research(2025)10.1007/s11095-025-03937-w

N/A

0DataRank · unranked

4 citations

Steven G. Chopski, Jae Hoon Lee, Fenggong Wang, Meng Hu, Andrew Babiskin +3 more

Emerging perspectives on leveraging physiologically based biopharmaceutics modeling (PBBM) for BCS class III biowaivers: A webinar summary

Journal of Pharmaceutical Sciences(2025)10.1016/j.xphs.2025.104030

N/A

0DataRank · unranked

1 citations

Shereeni Veerasingham, Yunming Xu, Alfredo García‐Arieta, Sivacharan Kollipara, Yuvaneshwari Kanagasabapathy +4 more